|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.588
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.513
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.460
|
Fly |
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.230
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.218
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.148
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.144
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.137
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.136
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.134
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.121
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.108
|
Fly |
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.105
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.105
|
Fly |
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.104
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.103
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.097
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.093
|
Mouse |
|
|
protein alkylation
|
GO:0008213 |
81 |
0.091
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.090
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.087
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.086
|
Fly |
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.084
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.083
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.078
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.077
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.077
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.077
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.077
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.075
|
|
|
|
neuroblast fate determination
|
GO:0007400 |
1 |
0.074
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.073
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.073
|
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.072
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.072
|
Fly |
|
|
gland development
|
GO:0048732 |
330 |
0.071
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.070
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.069
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.067
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.067
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.065
|
|
|
|
protein dna complex disassembly
|
GO:0032986 |
1 |
0.064
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.064
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.063
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.063
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.062
|
Fly |
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.062
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.062
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.060
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.059
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.058
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.058
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.058
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.057
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.056
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.056
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.055
|
|
|
|
detection of chemical stimulus involved in sensory perception of taste
|
GO:0050912 |
3 |
0.053
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.053
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.053
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.052
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.052
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.052
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.052
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.052
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.050
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.050
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.048
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.048
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.048
|
Fly |
|
|
histone modification
|
GO:0016570 |
159 |
0.047
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.047
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.047
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.046
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.046
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.046
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.045
|
Fly |
|
|
forebrain development
|
GO:0030900 |
302 |
0.045
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.045
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.045
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.044
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.044
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.044
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.044
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.043
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.043
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.043
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.042
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.042
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.042
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.042
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.040
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.040
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.040
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.039
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.039
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.039
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.038
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.038
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.038
|
Mouse |
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.038
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.037
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.037
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.037
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.037
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.036
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.036
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.036
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.036
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.036
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.036
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.036
|
Fly |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.036
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.036
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.036
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.035
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.035
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.035
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.035
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.035
|
Fly |
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.035
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.035
|
|
|
|
memory
|
GO:0007613 |
58 |
0.034
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.034
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.034
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.034
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.034
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.034
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.034
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.034
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.034
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.034
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.034
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.034
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.034
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.033
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.033
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.033
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.032
|
|
|
|
cerebral cortex neuron differentiation
|
GO:0021895 |
19 |
0.032
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.032
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.031
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.031
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.031
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.031
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.031
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.031
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.031
|
Fly |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.030
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.030
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.030
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.030
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.030
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.030
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.030
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.030
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.030
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.030
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.030
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.029
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.029
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.029
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.029
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.029
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.029
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.029
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.029
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.029
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.028
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.028
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.028
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.027
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.027
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.027
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.027
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.027
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.027
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.027
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.027
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.027
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.027
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.027
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.026
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.026
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.026
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.026
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.026
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.026
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.026
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.025
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.025
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.025
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.025
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.025
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.025
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.025
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.025
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.025
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.024
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.024
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.024
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.024
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.024
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.024
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.024
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.024
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.024
|
Mouse |
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.024
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.024
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.024
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.023
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.023
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.023
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.023
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.023
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.023
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.023
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.023
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.023
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.023
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.023
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.023
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.023
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.023
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.023
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.023
|
|
|
|
histone h4 deacetylation
|
GO:0070933 |
4 |
0.023
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.022
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.022
|
|
|
|
negative regulation of nlrp3 inflammasome complex assembly
|
GO:1900226 |
2 |
0.022
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.022
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.022
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.022
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.022
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.022
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.022
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.021
|
|
|
|
sperm ejaculation
|
GO:0042713 |
1 |
0.021
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.021
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.021
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.021
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.021
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.021
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.021
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.021
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.021
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.021
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.021
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.021
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.021
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.021
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.021
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.020
|
|
|
|
cerebellar granule cell precursor tangential migration
|
GO:0021935 |
1 |
0.020
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.020
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.020
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.020
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.020
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.020
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.020
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.020
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.020
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.020
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.020
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.020
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.020
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.019
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.019
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.019
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.019
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.019
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.019
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.019
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.019
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.019
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.019
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.019
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.019
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.019
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.019
|
Mouse |
|
|
response to sterol
|
GO:0036314 |
4 |
0.019
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.018
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.018
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.018
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.018
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.018
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.018
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.018
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.018
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.018
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.018
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.018
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.018
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.018
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.018
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.018
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.018
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.018
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.017
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.017
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.017
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.017
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.017
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.017
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.017
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.017
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.017
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.017
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.017
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.017
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.017
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.017
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.017
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.016
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.016
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.016
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.016
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.016
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.016
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.016
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.016
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.016
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.016
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.016
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.016
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.016
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.016
|
|
|
|
histone h3 k14 acetylation
|
GO:0044154 |
3 |
0.016
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.016
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.016
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.016
|
|
|
|
negative regulation of triglyceride metabolic process
|
GO:0090209 |
4 |
0.016
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.016
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.016
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.016
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.016
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.016
|
Fly |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.016
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.015
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.015
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.015
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.015
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.015
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.015
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.015
|
|
|
|
negative regulation of calcium ion dependent exocytosis
|
GO:0045955 |
3 |
0.015
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.015
|
|
|
|
habenula development
|
GO:0021986 |
2 |
0.015
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.015
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.015
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.015
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.015
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.015
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
14 |
0.015
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.015
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.015
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.015
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.015
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.015
|
|
|
|
regulation of presynaptic membrane organization
|
GO:1901629 |
3 |
0.015
|
|
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.015
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.015
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.015
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.015
|
|
|
|
histone h3 k9 acetylation
|
GO:0043970 |
5 |
0.015
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.015
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.015
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.015
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.014
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.014
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.014
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.014
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.014
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.014
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.014
|
|
|
|
learning
|
GO:0007612 |
98 |
0.014
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.014
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.014
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.014
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.014
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.014
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.014
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.014
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.014
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.014
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.014
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.014
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.014
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.014
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.014
|
Mouse |
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.014
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.014
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.014
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.013
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.013
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.013
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.013
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.013
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.013
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.013
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.013
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.013
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.013
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.013
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.013
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.013
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.013
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.013
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.013
|
|
|
|
ascending thin limb development
|
GO:0072021 |
2 |
0.013
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.013
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.013
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.013
|
|
|
|
rab protein signal transduction
|
GO:0032482 |
1 |
0.013
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.013
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.013
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.013
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.013
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.013
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.013
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.012
|
|
|
|
positive regulation of viral entry into host cell
|
GO:0046598 |
3 |
0.012
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.012
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
12 |
0.012
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.012
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.012
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.012
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.012
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.012
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.012
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.012
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.012
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.012
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.012
|
|
|
|
positive regulation of b cell chemotaxis
|
GO:2000538 |
2 |
0.012
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.012
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.012
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.012
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.012
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.012
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.012
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.012
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.012
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.012
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.012
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.012
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.012
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.012
|
|
|
|
ubiquitin dependent protein catabolic process via the multivesicular body sorting pathway
|
GO:0043162 |
3 |
0.012
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.012
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.012
|
|
|
|
proprioception
|
GO:0019230 |
4 |
0.012
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.012
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.012
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.012
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.011
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.011
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.011
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.011
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.011
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.011
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.011
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.011
|
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
37 |
0.011
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.011
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.011
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.011
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.011
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.011
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.011
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.011
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.011
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.011
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.011
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.011
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.011
|
|
